Earlier research primarily attributed the effects of mesenchymal stem cell (MSC) therapies to
their capacity for local engrafting and differentiating into multiple tissue types. However …

Background. Stem cell‐derived conditioned medium has a promising prospect to be
produced as pharmaceuticals for regenerative medicine. Objective. To investigate various …

Angiogenesis, the formation of new blood vessels by endothelial cells (ECs), is an adaptive
response to oxygen/nutrient deprivation orchestrated by vascular endothelial growth factor …

Stem cells obtained from amniotic fluid show high proliferative capacity in culture and
multilineage differentiation potential. Because of the lack of significant immunogenicity and …

The amniotic membrane (Amnio-M) has various applications in regenerative medicine. It
acts as a highly biocompatible natural scaffold and as a source of several types of stem cells …

Mesenchymal stromal cells (MSCs) are multipotent cells found in different tissues: bone
marrow, peripheral blood, adipose tissues, skeletal muscle, perinatal tissues, and dental …

Cardiovascular disease (CVD) is one of the leading causes of death in the Western world.
The replacement of damaged vessels and valves has been practiced since the 1950's …

The amniotic fluid has been identified as an untapped source of cells with broad potential,
which possess immunomodulatory properties and do not have the ethical and legal …

Arterial bypass grafts remain the gold standard for the treatment of end-stage ischaemic
disease. Yet patients unable to tolerate the cardiovascular stress of arterial surgery or those …

Human amniotic fluid stem cells (hAFS) have shown a distinct secretory profile and
significant regenerative potential in several preclinical models of disease. Nevertheless, little …